Search

Search

Other ways to explore content

EBRD projects News stories Contacts

EBRD lends €13.5 million to Polish lecithin producer LeciForce

Author: Nigina Mirbabaeva

Sunflower field
  • EBRD lends €13.5 million to LeciForce, a Polish producer of premium sunflower lecithin
  • Loan will finance new state-of-the-art manufacturing facility in Lublin, the first of its kind in Poland
  • Backed by an InvestEU guarantee, investment will support circular economy and resource efficiency in food processing

The European Bank for Reconstruction and Development (EBRD) is boosting Poland’s agrifood processing capability by extending a €13.5 million loan to LeciForce, a producer of premium sunflower lecithin products for food, cosmetic and pharmaceutical use. The financing will support the construction of LeciForce’s new state-of-the-art manufacturing facility in Lublin.

The new plant will be constructed in accordance with the highest resource efficiency standards and incorporate circular economy principles. It will be engineered to transform crude lecithin, a by-product of vegetable oil processing, into higher-grade, non-genetically modified organism (GMO) lecithin ingredients for European markets.

The plant is the first of its kind in Poland. It will help to boost European supply of premium food and pharmaceutical ingredients while demonstrating scalable circular economy solutions in agrifood manufacturing.

The Bank’s financing is supported by a first-loss guarantee from the European Union under its InvestEU programme.

LeciForce is a newly established company in Poland. The loan will be guaranteed by Agrosem Group, an existing EBRD client and one of the leading distributors of fertiliser, machinery, seeds and plant protection products in Ukraine.  

The EBRD is one of Poland’s leading institutional investors, having invested more than €16.6 billion in the country. 

Get email alerts for EBRD news stories

Sign up to get information on new stories, videos and events, tailored to your sector and location preferences.